We exemplify five TPKO signaling pathways, including the Toll-like receptor signaling pathway, the AGE-RAGE signaling pathway in diabetic complications, the MAPK signaling pathway, the NFκB signaling pathway, and the PD-L1 expression and PD-1 checkpoint pathway in cancer (Figure 13). The gene discussed is AGER; the disease is cancer.